51A Docetaxel (D), cisplatin (C) 5-fluorouracil (F) compared to cisplatin (C) and 5-fluorouracil (F) for chemotherapy-naive patients with metastatic or locally recurrent, unresectable gastric carcinoma (MGC): Interim results of a randomized phase III trial (V325)

Publication | Closed Access

DOI

Citations

References

2003

Year

E. Van Cutsem, Vladimir Moiseyenko, S. Tjulandin, M Fodor, C. Boni, Emmanuel Zuber, Sylvie Assadourian

European Journal of Cancer Supplements

Gastrointestinal OncologyMedicineMetronomic TherapyPathologyInterim ResultsMolecular OncologyUnresectable Gastric CarcinomaCancer TreatmentOncologyRadiation OncologyCancer ResearchChemotherapy-naive Patients